$90.54
0.941.05%
Last update: Oct 27, 1:33 PM
Kodiak Sciences Inc (KOD) Stock Price, Quote, News & History
KODNASDAQ
Regeneron stock drops as Kodiak Sciences reports Phase 3 wAMD data showing Zenkuda rivals Eylea with extended six-month dosing schedules.
You can purchase shares of Kodiak Sciences (NASDAQ:KOD) through any online brokerage.
Other companies in Kodiak Sciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Kodiak Sciences has a consensus price target of $55.73.
The stock price for Kodiak Sciences (NASDAQ: KOD) is $90.54 last updated October 27, 2026 at 1:33 PM EDT.
There are no upcoming dividends for Kodiak Sciences.
Kodiak Sciences does not have any upcoming earnings scheduled.
There is no upcoming split for Kodiak Sciences.
Kodiak Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's...
